Joincare Pharmaceutical Group Industry Co Ltd Strategic Asset Allocation Index

Latest as of June 2023: 28.4%

Joincare Pharmaceutical Group Industry Co Ltd strategic asset allocation index. Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Strategic Asset Allocation Index of 28.4% as of June 2023. Strategic assets (PP&E of CN¥6.19 Billion plus long-term investments of CN¥-) total CN¥6.19 Billion, measured against net assets of CN¥21.77 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Joincare Pharmaceutical Group Industry C's balance sheet to measure how much of total assets are equity-financed.

SAAI

28.4%
Strategic Assets / Net Assets

Strategic Assets

CN¥6.19 Billion
PP&E + LT Investments

PP&E

CN¥6.19 Billion
CNY

Net Assets

CN¥21.77 Billion
CNY

Strategic Asset Allocation Index of Joincare Pharmaceutical Group Industry Co Ltd (2000–2022)

Strategic asset allocation index of Joincare Pharmaceutical Group Industry Co Ltd from 2000 to 2022. This chart shows how Joincare Pharmaceutical Group Industry Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 28.4%, representing strategic assets of CN¥6.19 Billion against net assets of CN¥21.77 Billion CNY. Check Joincare Pharmaceutical Group Industry C (600380) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Joincare Pharmaceutical Group Industry Co Ltd Strategic Asset Allocation Index by Year (2000–2022)

Joincare Pharmaceutical Group Industry Co Ltd strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Joincare Pharmaceutical Group Industry Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Joincare Pharmaceutical Group Industry C stock valuation.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2022 27.8% CN¥6.12 Billion CN¥6.12 Billion CN¥- CN¥22.02 Billion ▼ -0.1 pp
2021 27.9% CN¥5.63 Billion CN¥5.63 Billion CN¥- CN¥20.18 Billion ▲ +1.7 pp
2020 26.2% CN¥5.05 Billion CN¥5.05 Billion CN¥- CN¥19.24 Billion ▼ -0.4 pp
2019 26.7% CN¥4.63 Billion CN¥4.63 Billion CN¥- CN¥17.38 Billion ▼ -12.4 pp
2018 39.1% CN¥6.36 Billion CN¥4.49 Billion CN¥1.87 Billion CN¥16.30 Billion ▲ +5.9 pp
2017 33.2% CN¥4.52 Billion CN¥4.52 Billion CN¥- CN¥13.62 Billion ▼ -33.1 pp
2016 66.3% CN¥6.19 Billion CN¥4.64 Billion CN¥1.55 Billion CN¥9.33 Billion ▼ -14.7 pp
2015 81.0% CN¥5.92 Billion CN¥4.83 Billion CN¥1.09 Billion CN¥7.31 Billion ▲ +9.7 pp
2014 71.3% CN¥4.66 Billion CN¥4.66 Billion CN¥- CN¥6.54 Billion ▼ -3.2 pp
2013 74.5% CN¥4.49 Billion CN¥4.49 Billion CN¥- CN¥6.02 Billion ▲ +8.8 pp
2012 65.7% CN¥3.67 Billion CN¥3.67 Billion CN¥- CN¥5.59 Billion ▲ +14.4 pp
2011 51.3% CN¥2.80 Billion CN¥2.80 Billion CN¥- CN¥5.46 Billion ▲ +5.7 pp
2010 45.6% CN¥2.42 Billion CN¥2.42 Billion CN¥- CN¥5.32 Billion ▼ -0.9 pp
2009 46.5% CN¥2.05 Billion CN¥2.05 Billion CN¥- CN¥4.40 Billion ▼ -6.4 pp
2008 52.8% CN¥2.04 Billion CN¥2.04 Billion CN¥- CN¥3.86 Billion ▲ +4.6 pp
2007 48.2% CN¥1.96 Billion CN¥1.96 Billion CN¥- CN¥4.07 Billion ▼ -16.1 pp
2006 64.3% CN¥1.85 Billion CN¥1.85 Billion CN¥- CN¥2.88 Billion ▲ +12.6 pp
2005 51.7% CN¥1.56 Billion CN¥1.56 Billion CN¥- CN¥3.03 Billion ▲ +10.1 pp
2004 41.6% CN¥1.24 Billion CN¥1.24 Billion CN¥- CN¥2.97 Billion ▲ +7.6 pp
2003 34.0% CN¥1.03 Billion CN¥1.03 Billion CN¥- CN¥3.03 Billion ▲ +16.5 pp
2002 17.6% CN¥353.50 Million CN¥353.50 Million CN¥- CN¥2.01 Billion ▲ +0.4 pp
2001 17.1% CN¥339.39 Million CN¥339.39 Million CN¥- CN¥1.98 Billion ▼ -99.1 pp
2000 116.2% CN¥299.50 Million CN¥299.50 Million CN¥- CN¥257.75 Million —
pp = percentage points